Download Complete Issue - Academic Journals
Download Complete Issue - Academic Journals
Download Complete Issue - Academic Journals
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2442 J. Med. Plants Res.<br />
Stability<br />
The stock solutions of the five active ingredients were<br />
found to be stable at room temperature based on the<br />
peak area of the five active ingredients over the time<br />
range of 0 to 24 h. (Table 2).<br />
Simultaneously determine five active ingredients<br />
HPLC incorporating UV detector was employed to<br />
simultaneously determine the five active ingredients in<br />
dried calyces of P. alkekengi were collected in six<br />
provinces of China. The powdered calyces were treated<br />
as in the “Sample preparation” section. The results<br />
indicated the variation of the five active ingredients in the<br />
calyces from different locations (Table 3). According to<br />
the Pharmacopoeia of PRC, the samples were qualified<br />
except the sample of s03 which have been collected from<br />
Xinchun, indicating that Luteoloside in relatively stable in<br />
the calyces.<br />
However, according to the overall contents. The sample<br />
s49 which been collected from Yangmadianzixiang<br />
contained the five active ingredients was the highest in all<br />
samples. According to the Table 3 the Luteolin, Physalin<br />
P and Physalin O had low levels and instability. Physalin<br />
A had high content and stability and it was the unique<br />
ingredients in the calyces. So we can establish the quality<br />
standards of the calyces that determined content of<br />
Physalin A.<br />
Conclusion<br />
A simple HPLC method was developed for the<br />
simultaneous determination the five active ingredients in<br />
dried calyces of P. alkekengi. The linearity, recovery and<br />
stability of the developed method were validated,<br />
respectively. From the results of this study, we know that<br />
the contents of the five active ingredients in the calyces<br />
major varied from different locations. In a word, the<br />
results can be taken as the evidence for the exploitation<br />
and utilization of the calyces reasonably.<br />
ACKNOWLEDGMENTS<br />
Thanks for the guidance of Prof. Yin haibo and Prof. Ying<br />
xixiang during the experiment.<br />
REFERENCES<br />
Angelica T Vierira, Vanessa Pinho, Lucilia B Lepsch (2005).<br />
Mechanisms of the anti-inflammatory effects of the natural<br />
secosteroids physalins in a model of intestinal ischaemia and<br />
reperfusion injury. Br. J. Pharmacol., 146: 244-251.<br />
Kawai M, Matsumoto A, Makino B (1993). The structure of physalin P. A<br />
new physalin from physalis alkekengi. Bull. Chem. Soc. Jpn., 66:<br />
1299.<br />
Kawai M, Matsuura T, Kyuno S, Matsuki H, Takenaka M (1987). A new<br />
physalin from physalis alkekengi structure of physalin L. Phytochem.,<br />
26: 3313.<br />
Kawai M, Ogura T, Nakamishi M, Mastsuura T (1988). Structure of<br />
Physalin isolated from physalis alkekengi Var. Francheti. Bull. Chem.<br />
Soc. Jpn., 61: 2969.<br />
Kazushi S, Shii Y (1992). Three new withanolides, physagulins A, B and<br />
D from physalis angulata. Chem, Pharm. Bull., 40(8): 2088.<br />
Matsuura T, Kawai M, Nakashima R, Butsugan YJ (1970) Structure of<br />
physalin A and Physalins B, 13, 14-Seco-16,24-cyclo-steroids froom<br />
Physalis Alkekengi Var. Francheti. Chem. Soc. C., p. 664.<br />
Melissa TG Silva, Sonia M Simas, Terezinha GFMB (2005). Studies on<br />
antimicrobial activity, in vitro, of Physalis angulata L (Solanaceae)<br />
fraction and physalin B bringing out the importance of assay<br />
determination. Mem. Inst. Oswaldo Cruz, Rio de Janeiro, 100(7):<br />
779-782.<br />
The Pharmacopoeia of People’s Republic of China (2010). Part<br />
Ⅰ.Beijing: China Publishing House of Trad. Chin. Med., p.337.<br />
Xu L, Wang RX, Yang YY, Wang B. (2009). Study on the resource of the<br />
Physalis in China. Chinese Wild Plant Resources, 28(1): 21-23.